Vanguard Group’s MGC Diagnostics Corporation MGCD Stock Holding History

Vanguard Group’s Portfolio MGCD Stock Details MGCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-80,771	Closed	-$724K	–	4091
2017 Q3	$724K	Buy	80,771 +363	+0.5%	+$2.95K	﹤0.01%	3673
2017 Q2	$682K	Hold	80,408	–	–	﹤0.01%	3668
2017 Q1	$672K	Hold	80,408	–	–	﹤0.01%	3686
2016 Q4	$619K	Hold	80,408	–	–	﹤0.01%	3689
2016 Q3	$555K	Hold	80,408	–	–	﹤0.01%	3739
2016 Q2	$524K	Hold	80,408	–	–	﹤0.01%	3780
2016 Q1	$489K	Buy	80,408 +74	+0.1%	+$487	﹤0.01%	3794
2015 Q4	$529K	Hold	80,334	–	–	﹤0.01%	3816
2015 Q3	$530K	Hold	80,334	–	–	﹤0.01%	3834
2015 Q2	$421K	Buy	80,334 +1,250	+2%	+$7.76K	﹤0.01%	3908
2015 Q1	$582K	Hold	79,084	–	–	﹤0.01%	3788
2014 Q4	$506K	Hold	79,084	–	–	﹤0.01%	3718
2014 Q3	$538K	Buy	79,084 +17,200	+28%	+$133K	﹤0.01%	3691
2014 Q2	$519K	Buy	61,884 +4,800	+8%	+$47.5K	﹤0.01%	3672
2014 Q1	$637K	Buy	57,084 +3,500	+7%	+$39.6K	﹤0.01%	3590
2013 Q4	$678K	Buy	53,584 +12,495	+30%	+$153K	﹤0.01%	3518
2013 Q3	$450K	Buy	41,089 +9,680	+31%	+$87K	﹤0.01%	3569
2013 Q2	$262K	Buy	+31,409	New	+$228K	﹤0.01%	3606

Other funds holding MGCD

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group's MGCD Position: Q4 2017 in Review

Vanguard Group sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 80,771 shares — an estimated $724K sold.

Vanguard Group first reported a position in MGCD in Q2 2013 and held it in 18 quarters. The position peaked at $724K in Q3 2017. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

Vanguard Group reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
Vanguard Group sold 80,771 MGC Diagnostics Corporation shares in Q4 2017, an estimated $724K.
Vanguard Group first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 18 quarters.
Vanguard Group's MGC Diagnostics Corporation position peaked at $724K in Q3 2017.
12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.